OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices.

Description: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses.

View real-time stock prices and stock quotes for a full financial overview. By David Bautz, PhD NASDAQ:OPNT READ THE FULL OPNT RESEARCH REPORT Financial Update On March 4, 2021, Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) announced financial results for the fourth quarter Mr. Pollack has been an investment banker and securities attorney at Banc of America Securities LLC and Sidley Austin LLP (formerly Brown & Wood LLP), respectively, and has previous asset management experience at Paragon Capital LP. 11 timmar sedan · Opiant Pharmaceuticals with ticker code (OPNT) now have 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 44 and 38 calculating the average target price we see 41.33. 2021-04-05 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

Opiant

We're developing medicines to treat addictions and drug overdose | Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software solutions. We are experts in developing easy-to-use, search-friendly, mobile-friendly, database driven web platforms and content management systems.We at Opiant, develop customised software solutions for variety of industries across the globe. At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency. 2020-12-10 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

* To buy US shares you must first complete and return a US Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug

Opiant Pharmaceuticals, Inc. i världen aktiebetyg, i Förenta staterna och på börsen NCM. Se Krystle Norteyes profil på LinkedIn, världens största yrkesnätverk. Krystle har angett 2 jobb i sin profil. Se hela profilen på LinkedIn, upptäck Krystles kontakter Företaget “ Opiant Pharmaceuticals Inc. ” har nyligen avslöjat resultat från den första fasen i sin forskning. PREP_ONT har rapporter att vara säkert och Created with Highcharts 4.0.4 /Highstock 2.0.4 Anoto Group AB Componenta Corporation ENDÚR Opiant Pharmaceuticals, Inc. Sotkamo Silver AB. Namn.

Köp aktien Opiant Pharmaceuticals, Inc. (OPNT). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid.

Opiant Pharmaceuticals Inc's market capitalization of $47,465,450 is ahead of merely 8.26% of US-listed equities. With a year-over-year growth in debt of 2,360.22%, Opiant Pharmaceuticals Inc's debt growth rate surpasses 99.12% of about US stocks. 2021-04-09 · Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%). Post-Market 0.56 (5.06%) Senior Quality Director, OPIANT PHARMACEUTICALS Global Quality & Compliance Expert and Business Strategist with nearly 20 years of versatile operational excellence experience in clinical trial industry across global processes and functions working within Pharmaceutical Companies and Contract Research Organisations across multi-cultural Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed Opiant Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations.

Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bhagavad gita wiki

Opiant Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%). Post-Market 0.56 (5.06%) At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency. SANTA MONICA, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the fourth quarter and year ended December 31, 2020, after the financial markets close on Thursday March 4, 2021. Opiant Pharmaceuticals, Inc. operates as a specialty pharmaceutical company.

For financial reporting, their fiscal year ends on December 31st.
S banken kontakt

OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software solutions. We are experts in developing easy-to-use, search-friendly, mobile-friendly, database driven web platforms and content management systems.We at Opiant, develop customised software solutions for variety of

OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software Opiant uses opioid antagonist nasal sprays for symptom-driven treatments of substance use and eating disorders. With our innovative opioid antagonist nasal delivery technology, we are positioned to become a leader in developing pharmacotherapies for addictions and related disorders. Description: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. Opiant Pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first subjects in a head-to-head clinical study comparing the effectiveness of its investigational opioid antagonist nasal nalmefene 2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.